WO2002062984A1 - The yeast with immunoregulation activity to the k cell as well as the production method and the use thereof - Google Patents

The yeast with immunoregulation activity to the k cell as well as the production method and the use thereof Download PDF

Info

Publication number
WO2002062984A1
WO2002062984A1 PCT/CN2001/000117 CN0100117W WO02062984A1 WO 2002062984 A1 WO2002062984 A1 WO 2002062984A1 CN 0100117 W CN0100117 W CN 0100117W WO 02062984 A1 WO02062984 A1 WO 02062984A1
Authority
WO
Grant status
Application
Patent type
Prior art keywords
cell
yeast
specific
biological preparations
immonological
Prior art date
Application number
PCT/CN2001/000117
Other languages
French (fr)
Inventor
Kamfu Wong
Original Assignee
Six Forest Bio-Science Institute Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts

Abstract

The invention involves a method of simulating bioelectricity to activate the recessive gene of normal yeast to convert it a specific yeast. The specific proteins (enzymes) expressed by the specific yeast have the ability to activate, modulate and correct the immune gene in the B cell, T cell, K cell and NK cell which have deficient immonological function, respectively. Further more, the specific yeast is made into biological preparations for regulating the immune gene to rebuild immonological function of the body, such that the individuals with various diseases can recuperate their health. The biological preparations of the invention may be used in preventing and treating various diseases such as multiple type of tumors, uraemia, hepatitis, senile dementia, various gastrointestinal disease, diabetes, neural obstruction etc. The effect of the biological preparations is perfect, while no toxicity and side-effect is observed.
PCT/CN2001/000117 2001-02-08 2001-02-08 The yeast with immunoregulation activity to the k cell as well as the production method and the use thereof WO2002062984A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/CN2001/000117 WO2002062984A1 (en) 2001-02-08 2001-02-08 The yeast with immunoregulation activity to the k cell as well as the production method and the use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2001/000117 WO2002062984A1 (en) 2001-02-08 2001-02-08 The yeast with immunoregulation activity to the k cell as well as the production method and the use thereof

Publications (1)

Publication Number Publication Date
WO2002062984A1 true true WO2002062984A1 (en) 2002-08-15

Family

ID=4574771

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2001/000117 WO2002062984A1 (en) 2001-02-08 2001-02-08 The yeast with immunoregulation activity to the k cell as well as the production method and the use thereof

Country Status (1)

Country Link
WO (1) WO2002062984A1 (en)

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1375652A3 (en) * 2002-06-28 2004-01-07 Ultra Biotech Limited Oral compositions for HIV-Infected Subjects
EP1375651A3 (en) * 2002-06-28 2004-01-07 Ultra Biotech Limited Oral compositions for white blood cell activation and proliferation
US6984508B2 (en) 2003-06-11 2006-01-10 Ultra Biotech Limited Biological compositions and methods for treatment of cervical cancer
US6984507B2 (en) 2003-06-11 2006-01-10 Ultra Biotech Limited Biological compositions and methods for treatment of lung cancer
US6987012B2 (en) 2003-06-11 2006-01-17 Ultra Biotech Limited Biological compositions and methods for treatment of colorectal cancer
US6989253B2 (en) 2003-06-11 2006-01-24 Ultra Biotech Limited Biological compositions and methods for treatment of testicular cancer
US7201906B2 (en) 2003-06-11 2007-04-10 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204986B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204988B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204987B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Biological compositions and methods for treatment of prostate cancer
US7208158B2 (en) 2003-06-11 2007-04-24 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7214377B2 (en) 2003-06-11 2007-05-08 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7220416B2 (en) 2003-06-11 2007-05-22 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223403B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223401B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223405B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepareompositions comprising yeast treated with electromagnetic energy
US7223402B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223404B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223400B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7226600B2 (en) 2003-06-11 2007-06-05 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
WO2011023769A1 (en) * 2009-08-26 2011-03-03 Mb Milmed Ab Composition for treatment of neurodegenerative diseases or disorders, method and use comprising electromagnetically irradiated yeast

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1185484A (en) * 1996-12-11 1998-06-24 阿尔瓦罗·V·皮卡卢加 Method for regulating cell conduction

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1185484A (en) * 1996-12-11 1998-06-24 阿尔瓦罗·V·皮卡卢加 Method for regulating cell conduction

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1375652A3 (en) * 2002-06-28 2004-01-07 Ultra Biotech Limited Oral compositions for HIV-Infected Subjects
EP1375651A3 (en) * 2002-06-28 2004-01-07 Ultra Biotech Limited Oral compositions for white blood cell activation and proliferation
US7220416B2 (en) 2003-06-11 2007-05-22 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US6984507B2 (en) 2003-06-11 2006-01-10 Ultra Biotech Limited Biological compositions and methods for treatment of lung cancer
US6987012B2 (en) 2003-06-11 2006-01-17 Ultra Biotech Limited Biological compositions and methods for treatment of colorectal cancer
US6989253B2 (en) 2003-06-11 2006-01-24 Ultra Biotech Limited Biological compositions and methods for treatment of testicular cancer
US7201906B2 (en) 2003-06-11 2007-04-10 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204986B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204988B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204987B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Biological compositions and methods for treatment of prostate cancer
US7208158B2 (en) 2003-06-11 2007-04-24 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7214377B2 (en) 2003-06-11 2007-05-08 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US6984508B2 (en) 2003-06-11 2006-01-10 Ultra Biotech Limited Biological compositions and methods for treatment of cervical cancer
US7223403B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223401B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223405B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepareompositions comprising yeast treated with electromagnetic energy
US7223402B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223404B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223400B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7226600B2 (en) 2003-06-11 2007-06-05 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
WO2011023769A1 (en) * 2009-08-26 2011-03-03 Mb Milmed Ab Composition for treatment of neurodegenerative diseases or disorders, method and use comprising electromagnetically irradiated yeast
CN102481368A (en) * 2009-08-26 2012-05-30 密美德有限公司 Composition for treatment of neurodegenerative diseases or disorders, method and use comprising electromagnetically irradiated yeast
JP2013503138A (en) * 2009-08-26 2013-01-31 エムビー ミルメド エービー Compositions for the treatment of neurodegenerative diseases or disorders, including electromagnetic radiation yeast, methods and uses
US9320768B2 (en) 2009-08-26 2016-04-26 Milmed Ab Composition for treatment of neurodegenerative diseases or disorders, method and use comprising electromagnetically irradiated yeast

Similar Documents

Publication Publication Date Title
Coates et al. The future challenges facing the development of new antimicrobial drugs
Wolpaw Brain–computer interfaces as new brain output pathways
Schmieder et al. Insights into antibiotic resistance through metagenomic approaches
Polk et al. The neural development and organization of letter recognition: Evidence from functional neuroimaging, computational modeling, and behavioral studies
Olshansky et al. In pursuit of the
Falconer et al. Health risk assessment of cyanobacterial (blue-green algal) toxins in drinking water
D'argenio et al. Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients
Drews In quest of tomorrow's medicines
Wilcox Conservative Protestant childrearing: Authoritarian or authoritative?
Szyperski et al. Structure comparison of human glioma pathogenesis-related protein GliPR and the plant pathogenesis-related protein P14a indicates a functional link between the human immune system and a plant defense system
Belzung et al. Criteria of validity for animal models of psychiatric disorders: focus on anxiety disorders and depression
Yin et al. Lesions of dorsolateral striatum preserve outcome expectancy but disrupt habit formation in instrumental learning
Koekkoek et al. Cerebellar LTD and learning-dependent timing of conditioned eyelid responses
Nettle Ecological influences on human behavioural diversity: A review of recent findings
Hartmann et al. Excessive hippocampal acetylcholine levels in acetylcholinesterase‐deficient mice are moderated by butyrylcholinesterase activity
Wilkinson et al. Social determinants of health: the solid facts
Berg et al. The recombinant DNA controversy: twenty years later.
Parr The evolution of face processing in primates
Quinsey et al. Juvenile delinquency: Understanding the origins of individual differences.
Achilladelis et al. The dynamics of technological innovation: the case of the pharmaceutical industry
Kanazawa Evolutionary psychology and intelligence research.
Hang et al. A 55-kDa protein isolated from human cells shows DNA glycosylase activity toward 3, N4-ethenocytosine and the G/T mismatch
Svensson et al. Characterization of muscarinic receptor subtypes in Alzheimer and control brain cortices by selective muscarinic antagonists
WO2003029401A8 (en) Peptidoglycan recognition protein encoding nucleic acids and methods of use thereof
Daley et al. Intracellular gene transfer: reduced hydrophobicity facilitates gene transfer for subunit 2 of cytochrome c oxidase

Legal Events

Date Code Title Description
AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 69(1) EPC

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: JP